Quantcast

West LA Times

Saturday, November 23, 2024

GT Biopharma to Participate in the H.C Wainwright 24th Annual Global Investment Conference in September

GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE® platform, today announced that management will present in-person at H.C. Wainwright’s 24th Annual Global Investment Conference taking place September 12-14, 2022 at the Lotte New York Palace. Company management will also be participating in 1x1 meetings during the event.

H.C. Wainwright 24th Annual Global Investment Conference – September 12-14, 2022
  
Title:GT Biopharma (GTBP) Company Presentation
Date:Tuesday, September 13, 2022
Time:10:30 – 11:00 am EDT
Location:Kennedy II, 4th Floor, Lotte New York Palace
Webcast Link:Register here
*a replay of the presentation will be available for 90 days
If you are interested in arranging a 1x1 meeting request with management, please contact your bank conference representative. To access the archived recording for replay, please see the Presentations section of GT Biopharma’s corporate website.

Original source can be found here.

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS